Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT01602185
PHASE2

Study of NMDA Antagonists and Neuropathic Pain

Sponsor: University Hospital, Clermont-Ferrand

View on ClinicalTrials.gov

Summary

The aim of this study is to evaluate if memantine or dextromethorphan gave in relay to ketamine maintains or induces a decrease of pain intensity. In clinical, after ketamine cure, clinicians have often difficulties to treat patients in order to maintain analgesia or suggest another treatment if analgesia induced by ketamine was not effective, which occurs in one quarter of patients. It will be very useful for monitoring of painful patients evaluate if memantine or dextromethorphan could be an effective therapeutic alternative in neuropathic pain treatment.

Official title: Antagonists NMDA in Relay to Ketamine in Neuropathic Pain

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

7

Start Date

2012-05

Completion Date

2016-09-07

Last Updated

2026-04-21

Healthy Volunteers

No

Interventions

DRUG

Dextromethorphan (drug used like antitussive)

The aim of this study is to evaluate if memantine or dextromethorphan gave in relay to ketamine maintains or induces a decrease of pain intensity

DRUG

Memantine (drug used in Alzheimer's disease)

The aim of this study is to evaluate if memantine or dextromethorphan gave in relay to ketamine maintains or induces a decrease of pain intensity

DRUG

Placebo (lactose)

The aim of this study is to evaluate if memantine or dextromethorphan gave in relay to ketamine maintains or induces a decrease of pain intensity

Locations (1)

CHU Clermont-Ferrand

Clermont-Ferrand, France